Price (delayed)
$1.3
Market cap
$11.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$16.48
Enterprise value
$11.39M
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset ...
Highlights
WINT's EPS has surged by 95% year-on-year and by 41% since the previous quarter
The company's net income has surged by 61% YoY and by 15% QoQ
The equity has declined by 41% year-on-year but it has increased by 26% since the previous quarter
Windtree Therapeutics's quick ratio has shrunk by 92% YoY and by 24% QoQ
Key stats
What are the main financial stats of WINT
MarketValuationsEarnings
Shares outstanding
8.99M
Market cap
$11.69M
Enterprise value
$11.39M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.17
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$25.56M
Net income
-$9.71M
EBIT
-$9.45M
EBITDA
-$8.95M
Free cash flow
-$15.28M
Per shareBalance sheetLiquidity
EPS
-$16.48
EPS diluted
-$16.48
Free cash flow per share
-$17.23
Book value per share
$7.45
Revenue per share
$0
TBVPS
$5.86
Total assets
$30.45M
Total liabilities
$23.9M
Debt
$2.01M
Equity
$4.41M
Working capital
-$10.5M
Debt to equity
0.46
Current ratio
0.27
Quick ratio
0.16
Net debt/EBITDA
0.03
MarginsEfficiencyDividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-35.2%
Return on equity
-160.3%
Return on invested capital
N/A
Return on capital employed
-59%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WINT stock price
How has the Windtree Therapeutics stock price performed over time
Intraday
5.69%
1 week
-16.67%
1 month
-42.22%
1 year
-81.16%
YTD
272.17%
QTD
3.17%
Financial performance
How have Windtree Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.56M
Net income
-$9.71M
Gross margin
N/A
Net margin
N/A
WINT financials
The company's net income has surged by 61% YoY and by 15% QoQ
The operating income has grown by 3.4% YoY
Growth
What is Windtree Therapeutics's growth rate over time
WINT growth chart
Valuation
What is Windtree Therapeutics stock price valuation
P/E
N/A
P/B
0.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Price to earnings (P/E)
WINT's EPS has surged by 95% year-on-year and by 41% since the previous quarter
Price to book (P/B)
The price to book (P/B) is 79% less than the 5-year quarterly average of 0.8 and 66% less than the last 4 quarters average of 0.5
The equity has declined by 41% year-on-year but it has increased by 26% since the previous quarter
Price to sales (P/S)
Efficiency
How efficient is Windtree Therapeutics business performance
The return on assets is up by 47% year-on-year
The company's return on equity rose by 42% YoY but it fell by 4.8% QoQ
Dividends
What is WINT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WINT.
Financial health
How did Windtree Therapeutics financials performed over time
Assets vs liabilities
The company's total assets is 27% higher than its total liabilities
Windtree Therapeutics's quick ratio has shrunk by 92% YoY and by 24% QoQ
The current ratio has dropped by 89% year-on-year but it rose by 17% since the previous quarter
Debt vs equity
WINT's debt is 54% lower than its equity
The company's debt to equity has surged by 59% YoY but it has shrunk by 53% QoQ
The equity has declined by 41% year-on-year but it has increased by 26% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.